Levosert

Levonorgestrel, the active ingredient in Levosert, is a progestin presented as a 52 mg intrauterine system for intrauterine use. It provides long‑acting reversible contraception for women of reproductive age. GNH USA supplies Levosert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levosert, a hormonal intrauterine contraceptive, is used for prevention of pregnancy.

Long‑acting reversible contraception: provides up to five years of pregnancy prevention. Contraception for women seeking intrauterine method: offers high efficacy and convenience. Prevention of unintended pregnancy: reduces risk of pregnancy in sexually active women.

Levosert may cause local and systemic adverse reactions.

Common Side Effects: - Irregular bleeding: spotting or changes in menstrual pattern. - Pelvic pain or cramping: discomfort after insertion. - Headache: mild to moderate. - Breast tenderness: soreness or swelling. - Acne: mild skin eruptions.

Serious or Rare Side Effects: - Uterine perforation: rare injury during insertion. - Device expulsion: loss of the intrauterine system. - Infection: pelvic inflammatory disease. - Ectopic pregnancy: pregnancy occurring outside the uterus.

Before insertion, clinicians should assess eligibility and counsel patients on possible outcomes.

Eligibility assessment: confirm non‑pregnant status and absence of uterine anomalies. Contraindications review: avoid in women with active pelvic infection or known hypersensitivity to levonorgestrel. Insertion timing: place within 5 days of menstrual onset or after a negative pregnancy test. Follow‑up evaluation: schedule check after insertion to ensure correct placement. Patient counseling: discuss possible changes in bleeding patterns and signs of complications. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levosert can interact with other medicines that affect hormone metabolism.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine): may reduce levonorgestrel efficacy. - Antifungal azoles (e.g., ketoconazole): may increase levonorgestrel levels, risk of side effects.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., tetracycline): possible slight reduction in contraceptive effect. - Herbal supplements (e.g., St. John’s wort): may decrease hormone levels. - Antiretrovirals (e.g., protease inhibitors): may alter hormone metabolism.